Corporate ActionAug 7, 2026, 04:21 PM
BioStem Technologies Uplists to Nasdaq Capital Market
AI Summary
BioStem Technologies, Inc. announced that its shares of common stock have been approved for listing on The Nasdaq Capital Market. Trading commenced on Nasdaq on August 7, 2026, under the existing ticker symbol "BSEM," transitioning from the OTCID Basic Market. CEO Jason Matuszewski highlighted this as a significant milestone, anticipating expanded access to capital, improved market visibility, and increased liquidity for shareholders.
Key Highlights
- BioStem Technologies' common stock approved for listing on The Nasdaq Capital Market.
- Trading transitioned from the OTCID Basic Market to Nasdaq effective August 7, 2026.
- The company's common stock will continue to trade under its current ticker symbol "BSEM."
- CEO Jason Matuszewski stated the uplisting is an important milestone, reflecting significant progress.
- The uplisting is expected to expand access to capital, improve market visibility and liquidity for shareholders.
- Shareholders are not required to take any action in connection with the listing.
Price Impact